Results 21 to 30 of about 318,139 (404)
Introduction Occipital nerve stimulation (ONS) is used to treat therapy-resistant chronic migraine. Clinical use has resulted in a wide intraindividual and interindividual variation of clinical efficacy.
Carl H. Göbel +8 more
doaj +1 more source
Several factors can contribute to the development and chronification of migraines, including stress, which is undoubtedly a major trigger. Beyond pharmacotherapy, other treatment methods also exist, including behavioral techniques aiming at reducing ...
Dóra Dobos +20 more
doaj +1 more source
The Migraine Stigma Kaleidoscope View
The stigma of migraine, despite an impressive body of data on the epidemiological of migraine and the associated disability, burden and cost of migraine to patients, has not been fully evaluated as an important factor in the chronicization of the disease
Elena Gross +2 more
doaj +1 more source
Atogepant for the Preventive Treatment of Migraine.
BACKGROUND Atogepant is an oral, small-molecule, calcitonin gene-related peptide receptor antagonist that is being investigated for the preventive treatment of migraine. METHODS In a phase 3, double-blind trial, we randomly assigned adults with 4 to 14
J. Ailani +7 more
semanticscholar +1 more source
Stroke and migraine is there a possible comorbidity? [PDF]
The association between migraine and stroke is still a dilemma for neurologists. Migraine is associated with an increased stroke risk and it is considered an independent risk factor for ischaemic stroke in a particular subgroup of patients.
Del Balzo, Francesca +7 more
core +2 more sources
Introduction Depression is the most common comorbidity of migraine. The brain of migraineurs with depression shows differences compared to migraine only or depression only patients.
K. Gecse +8 more
doaj +1 more source
Ophthalmoplegic Migraine: Migrainous or Inflammatory? [PDF]
Contains fulltext : 58890.pdf (Publisher’s version ) (Open Access)
Dussen, D.H. van der +3 more
openaire +3 more sources
Background Chronic migraine (CM) is associated with substantial economic burden. Real-world data suggests that onabotulinumtoxinA treatment for CM reduces healthcare resource utilisation (HRU) and related costs.
Katja Kollewe +3 more
doaj +1 more source
Favorable outcome of early treatment of new onset child and adolescent migraine-implications for disease modification. [PDF]
There is evidence that the prevalence of migraine in children and adolescents may be increasing. Current theories of migraine pathophysiology in adults suggest activation of central cortical and brainstem pathways in conjunction with the peripheral ...
A Ferrari +52 more
core +1 more source
Familial aggregation of migraine and depression: Insights from a large Australian twin sample [PDF]
Free to read\ud \ud Objectives: This research examined the familial aggregation of migraine, depression, and their co-occurrence.\ud \ud Methods: Diagnoses of migraine and depression were determined in a sample of 5,319 Australian twins.
Heath, Andrew C +5 more
core +3 more sources

